Table 5.
Comparison Genotype and allele frequencies of rs5882 with risk of CAD in healthy and patient men and women
| Polymorphism | Genotypes | Alleles | ||||||
|---|---|---|---|---|---|---|---|---|
| GG (%) | GA (%) | AA (%) | p-value | G | A | O.R (95% CI) | p-value | |
| Men | ||||||||
| CETP rs5882 | 2.54 (1.44, 4.48) | |||||||
| Controls (n = 42) | 8 (19%) | 21 (50%) | 13 (30.9%) | 0.007 | 37 (44.0%) | 47 (56.0%) | 0.001 | |
| Patients (n = 63) | 30 (47.7%) | 24 (38%) | 9 (14.3%) | 84 (66.6%) | 42 (33.3%) | |||
| Women | ||||||||
| CETP rs5882 | 0.79 (0.44, 1.42) | |||||||
| Controls (n = 58) | 20 (34.5%) | 31 (53.5%) | 7 (12%) | 0.695 | 71 (61.2%) | 45 (38.8%) | 0.428 | |
| Patients (n = 37) | 10 (27%) | 21 (56.8%) | 6 (16.2%) | 41 (55.4%) | 33 (44.6%) | |||